German biotech firm BioNTech (22UAy.DE), has agreed to acquire domestic peer CureVac, for about $1.25 billion worth of BioNTech shares, it said on Thursday, to boost its work on new mRNA-based cancer treatments.
Under the deal, which pairs two former rivals in the race to develop COVID-19 vaccines, CureVac shareholders stand to receive a premium of 55% over the three-month average share price, and leave them with a stake of about 4%-6% in BioNTech, the suitor said.
CureVac's Frankfurt-listed shares surged 27% to a five-month high, valuing the company at €1.04 billion ($1.2 billion), while BioNTech shares were down 2%.
The deal further underscores BioNTech's long-term pursuit of new cancer treatments as it aims to show that its success as Pfizer's COVID-19 vaccine partner, which left its balance sheet flush with billions of euros in cash, was not a fluke.
"With the acquisition, BioNTech aims to strengthen the research, development, manufacturing, and commercialization of investigational mRNA-based cancer immunotherapy," the company said.
CureVac opted to focus on oncology about a year ago when it agreed to sell its remaining influenza and COVID-19 vaccine development to alliance partner GSK.
It had previously cut jobs as it sought to move beyond its failure to develop an mRNA-based COVID vaccine during the pandemic.
GERMAN BIOTECH CHAMPION
The agreement is also set to end CureVac's years-long legal fight over alleged mRNA patent infringement by BioNTech and for a share of vaccine revenues, where CureVac has made little progress.
CureVac shares were worth as much as €120 in December 2020 on hopes it would develop a COVID vaccine, more than double their initial public offer value in August of that year. They are now trading at €4.65.
BioNTech won a major shot in the arm for its cancer drug activities last week when Bristol Myers Squibb agreed to pay up to $11.1 billion to jointly develop a next-generation cancer immunotherapy that could take on rival Merck & Co's best-selling drug Keytruda.
Each CureVac share will be exchanged for about $5.46 in BioNTech American depositary shares, or ADS, but subject to a so-called collar mechanism, BioNTech said.
If the 10-day volume-weighted average price of BioNTech ADS shortly before the closing of the offer exceeds $126.55, the exchange ratio would be 0.04318, and if the price is lower than $84.37, the exchange ratio would be 0.06476.
BioNTech said the deal was supported by SAP SE co-founder and football investor Dietmar Hopp, who holds a stake of about 37% in CureVac.
The German government, owner of about 13% in CureVac for its financial backing during the pandemic, said it welcomed in principle the creation of a "new German biotech champion", and that it would review the offer.
Madagascar’s coup leader, Colonel Michael Randrianirina, who seized power earlier this month, appointed businessman and consultant Herintsalama Raja...
Ukrainian President Volodymyr Zelenskyy will join a meeting of Ukraine’s allies, known as the “coalition of the willing,” in London on Friday, F...
Amazon's AMZN.O cloud services unit AWS was struggling to recover on Monday from a widespread outage that knocked out thousands of websites along with...
China accused Britain of lacking “credibility and ethics” after the UK government once again postponed a decision on Beijing’s proposal to build...
Nexperia’s China unit has told its employees to follow directives from local management and disregard instructions from the company’s Dutch head o...
The World Health Organization (WHO) has warned that Afghanistan is facing a worsening humanitarian and health crisis in 2025, with millions of returning refugees expected to stretch the country’s already fragile health system.
Qantas Airways has been fined A$90 million ($58.64 million) for illegally firing 1,800 ground staff during the COVID-19 pandemic and replacing them with contractors, the Federal Court of Australia said on Monday (August 18).
The COVID-19 pandemic exposed deep flaws in how the world prepares for and responds to global health threats. From overwhelmed hospitals to fragmented international coordination, the crisis revealed that preparedness goes beyond stockpiles. It requires trust, transparency, and global cooperation.
Honduras has brought back mask mandates as COVID-19 cases and a new variant surge nationwide.
At least 69 people have died and almost 150 injured following a powerful 6.9-magnitude earthquake off the coast of Cebu City in the central Visayas region of the Philippines, officials said, making it one of the country’s deadliest disasters this year.
A tsunami threat was issued in Chile after a magnitude 7.8 earthquake struck the Drake Passage on Friday. The epicenter was located 135 miles south of Puerto Williams on the north coast of Navarino Island.
The war in Ukraine has reached a strategic impasse, and it seems that the conflict will not be solved by military means. This creates a path toward one of two alternatives: either a “frozen” phase that can last indefinitely or a quest for a durable political regulation.
A shooting in Nice, southeastern France, left two people dead and five injured on Friday, authorities said.
Snapchat will start charging users who store more than 5GB of photos and videos in its Memories feature, prompting backlash from long-time users.
Johnson & Johnson (J&J) is facing its first lawsuits in the United Kingdom over claims that its talc-based products cause cancer, as it continues to battle tens of thousands of similar cases in the United States.
The World Health Organization on Monday issued a health advisory warning about three contaminated cough syrups identified in India, urging authorities to report any detection of these medicines in their countries to the health agency.
Around 6,000 students in Malaysia have been infected with influenza and some schools have been closed for the safety of children and staff, an education ministry official said.
Indian police have arrested the owner of Sresan Pharmaceutical Manufacturer, the cough syrup company linked to the deaths of at least 19 children in the central state of Madhya Pradesh, a senior police officer told Reuters on Thursday.
More than 200 health facilities in war-hit eastern Congo have run out of medicines due to widespread looting and supply chain disruptions during fighting this year, the International Committee of the Red Cross (ICRC) said on Wednesday.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment